MK 0941

Alternative Names:
MK-0941

Latest Information Update: 04 Nov 2018

Price :
$50
*

* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

Originator
Merck & Co

Class
Antihyperglycaemics

Mechanism of Action
Glucokinase stimulants

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No

Highest Development Phases

Discontinued
Type 2 diabetes mellitus

Most Recent Events

24 Jun 2018
Biomarkers information updated

24 Sep 2010
Efficacy and safety data from three phase II trials in Type-2 diabetes mellitus presented at the 46th Annual Meeting of the European Association for the Study of Diabetes (EASD-2010)